GNOM: Global X Genomics & Biotechnology ETF
Performance
Watchlist
Select an item
Summary
GNOM at a glance
GNOM returned +39.51% over the past year and -6.86% a year over five years. Its worst drop in that year was -18.67%, smaller than 29% of ETFs on Redstone, and its Sharpe ratio of 1.01 beats 87% of ETFs on Redstone. It yields 1.10%.
Current Drawdown
-18.34%
Rolling Volatility
52.17%
Dividends
GNOM dividends
Yield
1.10%
Paid, past year
$0.65
Pays
Twice a year
Growth a year
—
Per share, by year
Yearly return over 5 years
GNOM paid $0.65 a share over the past year, twice a year. With dividends reinvested it returned -6.86% a year over five years, against -7.14% on price alone.
›All 4 payments since Dec 30, 2021
- Jun 29, 2026$0.0579
- Dec 30, 2025$0.5912
- Jun 27, 2025$0.0331
- Dec 30, 2021$0.026
Metrics
Risk Indicators
Profile
About GNOM
The Global X Genomics & Biotechnology ETF seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Solactive Genomics Index.
From its prospectus, filed Mar 31, 2026- Category
- Health Care
- Expense ratio
- 0.50%
- Fund size
- $110M
- Inception
- Apr 2019
Rankings
Lists GNOM is on
Comparisons